P

Assignee

FERRER INT

ES42 patents

Top patents by PatentIndex Score

US5665736ASep 9, 1997

N-benzoylmethyl-piperidines

FERRER INT8 citations72
US5395841AMar 7, 1995

4-benzylpiperidines for treating phychosis

FERRER INT12 citations72
US4883797ANov 28, 1989

Derivatives of piperazine, method for making the same

FERRER INT10 citations72
US4859675AAug 22, 1989

1-[2-(phenylmethyl) phenyl]piperazines as antidepressants

FERRER INT12 citations72
US5939555AAug 17, 1999

Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate

FERRER INT10 citations68
US6881845B2Apr 19, 2005

Process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine

FERRER INT8 citations67
US5135943AAug 4, 1992

1H-imidazole derivative compounds and pharmaceutical compositions containing the same

FERRER INT12 citations67
US5561135AOct 1, 1996

N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds

FERRER INT9 citations63
US6187793B1Feb 13, 2001

7-[(Piperidin-1-YL)-Propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use

FERRER INT2 citations61
US4767767AAug 30, 1988

2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities

FERRER INT2 citations61
US4535159AAug 13, 1985

Process for producing 1-position amino-derivatives of 1-(3',4'-methylenedioxyphenyl)propane-2-ol

FERRER INT5 citations61
US5736558AApr 7, 1998

4-(6-fluoro-1,2-benzisoxazolyl)-1 piperidinyl-propoxy-chromen-4-one-one-derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety

FERRER INT4 citations60
US4610998ASep 9, 1986

Imidazolylethoxyindanes and use as antithrombotic agents

FERRER INT5 citations60
US5973155AOct 26, 1999

Process for preparing (-)-trans-N-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-[[3,4-(methylened ioxy)phenoxy]methyl]-piperidine

FERRER INT2 citations59
US5643927AJul 1, 1997

4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia

FERRER INT4 citations59
US7635691B2Dec 22, 2009

Use of CDP-choline for the prophylactic treatment of cerebral ischemia

FERRER INT2 citations58
US6930096B2Aug 16, 2005

Use of CDP-choline for the prophylactic treatment of cerebral ischemia

FERRER INT4 citations58
US4728655AMar 1, 1988

Sulfonamidines, process for the production thereof and pharmaceutical compositions containing the same

FERRER INT3 citations58
US7759351B2Jul 20, 2010

Oxazolidinone compounds, and compositions and methods related thereto

FERRER INT4 citations56
US7323433B2Jan 29, 2008

R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole

FERRER INT2 citations53
US4719225AJan 12, 1988

Thiophene ring-substituted α-(alkylaminopropionyl)-thiophenes and the method for preparing the same

FERRER INT0 citations51
US10072000B2Sep 11, 2018

Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines

FERRER INT0 citations50
US8039476B2Oct 18, 2011

Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide

FERRER INT1 citations50
US8008486B2Aug 30, 2011

Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

FERRER INT0 citations50
US6348605B1Feb 19, 2002

Process for preparing 3-hydroxymethyl chromen-4-ones

FERRER INT0 citations50
US5798361AAug 25, 1998

5H-thiazolo 3,2-a!pyrimidin-5-one derivatives

FERRER INT0 citations50
US4843165AJun 27, 1989

Process for preparing a 2,3-dihydro-1H-imidazolyl-ethoxy indene antithrombotic agent and its pharmaceutically acceptable salts

FERRER INT1 citations50
US6005115ADec 21, 1999

Forms A and B of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl ]thio]ethyl]ami no]methylene]-4-bromo-benzenesulfonamide

FERRER INT0 citations48
US4603134AJul 29, 1986

Piperazine derivative and pharmaceutical composition containing the same

FERRER INT1 citations48
US4600780AJul 15, 1986

N-cyano-formamidines

FERRER INT1 citations48
US10022363B2Jul 17, 2018

Pharmaceutical topical compositions

FERRER INT0 citations47
US9399014B2Jul 26, 2016

Pharmaceutical topical compositions

FERRER INT0 citations45
US6894032B2May 17, 2005

Use of CDP-choline for the treatment of alcohol withdrawal syndrome

FERRER INT0 citations45
US7470814B1Dec 30, 2008

Process for the preparation of substituted 7-allyl-6-hydroxy-indanes

FERRER INT0 citations44
US12533371B2Jan 27, 2026

Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof

FERRER INT0 citations43
US7947688B2May 24, 2011

N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto

FERRER INT0 citations35
US7943611B2May 17, 2011

Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof

FERRER INT0 citations35
US5852021ADec 22, 1998

Polymorph B of 1-(diphenylmethyl)-4- 3-(2-phenyl-1,3-dioxolan-2-YL) propyl! piperazine

FERRER INT1 citations33
US7829726B2Nov 9, 2010

Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof

FERRER INT0 citations32
US7626038B2Dec 1, 2009

Method for manufacturing enantiomeric imidazole compounds

FERRER INT0 citations32
US7205405B2Apr 17, 2007

Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one

FERRER INT0 citations31
US10617699B2Apr 14, 2020

Oral formulation for the treatment of cardiovascular diseases

FERRER INT0 citations21